Quantcast

Latest Pulmonology Stories

2014-02-04 16:28:20

Chief Medical Officer and Chairman of the Steering Committee for the PFF Care Center Network and PFF Patient Registry Announced CHICAGO, Feb. 4, 2014 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) today announced two key additions to their staff. Gregory P. Cosgrove, MD, has been named Chief Medical Officer and Kevin R. Flaherty, MD, MS, has been named Chairman of the Steering Committee of the PFF Care Center Network and PFF Patient Registry. "We are pleased to...

2014-02-03 12:26:59

REHOVOT, Israel, February 3, 2014 /PRNewswire/ -- Advanced Inhalation Therapies (AIT), a leader in the development of nitric oxide (NO) therapeutics for the treatment of infectious respiratory diseases announced today that its lead investigator will present clincial trial results at the upcoming 2014 Israeli clinical Pediatric Society - The Annual Meeting of the Israeli Association of Clinical Pediatrics in Tel-Aviv, Israel, February 5, 2014. The presentation entitled...

2014-01-28 23:28:23

Asthma is a very complicated health condition that patients have to deal with on a daily basis. Through AsthmaMist, the most efficient first-aid for asthma becomes fully accessible. San Diego,Ca (PRWEB) January 28, 2014 Asthma doesn’t have to be a disease that cripples a person or changes the way he lives his life. Once everybody realizes that all that is required to put asthma at bay are simple lifestyle changes and proper medications, living with asthma becomes simpler and less...

2014-01-28 08:29:28

Digital device provides objective data to reduce air leaks and improve outcomes MCHENRY, Ill., Jan. 28, 2014 /PRNewswire/ -- Medela Healthcare announced research results showing that surgical patients who were managed with digital chest drainage system Thopaz(TM) had a significantly shorter postoperative length of stay and chest tube duration, due to reduced air leak duration, compared to those managed with traditional devices. Results from a recent global study that included 400...

2014-01-27 16:25:06

WINSTON-SALEM, N.C., Jan. 27, 2014 /PRNewswire-USNewswire/ -- More than 25 million people in the United States have asthma, a chronic lung disease that inflames and narrows the airways causing recurring periods of wheezing, chest tightness, shortness of breath and coughing. (Logo: http://photos.prnewswire.com/prnh/20111114/DC06171LOGO) Although several types of drugs are available to treat asthma, long-acting beta agonists (LABAs) are among the most commonly used and work well for...

2014-01-27 14:57:08

More than 25 million people in the United States have asthma, a chronic lung disease that inflames and narrows the airways causing recurring periods of wheezing, chest tightness, shortness of breath and coughing. Although several types of drugs are available to treat asthma, long-acting beta agonists (LABAs) are among the most commonly used and work well for most people. However, for a small subgroup of people with asthma, LABAs can cause severe, life-threatening side effects and carry a...

2014-01-24 11:50:33

The Annals of the American Thoracic Society has released a comprehensive supplement on the 56th annual Thomas L. Petty Aspen Lung Conference entitled "The Lung Microbiome: A New Frontier in Pulmonary Medicine." More than 170 microbiologists, basic respiratory scientists, and pulmonary clinicians traveled from nine countries to convene at the three-day conference, which took place in June 2013 in Aspen, CO. Research from 12 state-of-the-art speakers, 24 oral research presentations, and 20...

2014-01-23 04:21:29

OXFORD, England, January 23, 2014 /PRNewswire/ -- First clinical data from PSX1002, a novel, orally inhaled, drug-only, pMDI suspension formulation of glycopyrronium bromide, a long-acting muscarinic antagonist (LAMA) Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces positive top-line results from its Phase 2 clinical study with...

2014-01-20 12:24:00

LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth Summary GBI Research, a leading business intelligence provider, has released its latest research report, "Asthma Therapeutics Market to 2019 -...

2014-01-14 12:26:46

BETHESDA, Md., Jan. 14, 2014 /PRNewswire/ -- Evidera, a leading provider of evidence-based solutions for the healthcare industry, announced that the Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, has released its first draft qualification guidance document for a patient-reported outcome (PRO) measure in drug development: Qualification of Exacerbations of Chronic Pulmonary Disease Tool [EXACT] for Measurement of Symptoms of Acute Bacterial...


Latest Pulmonology Reference Libraries

0_f9fe10c6664d20ba0d9091907b66a65f
2011-01-05 16:00:36

Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...

More Articles (1 articles) »
Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related